Publications by authors named "Hua-Qiang Bi"

Claim this Profile
R
Recombinant human type-5 adenovirus (H101) combined with radiofrequency ablation versus traditional radiofrequency ablation for hepatocellular carcinoma ≤ 3 cm: a phase III randomized controlled trial.
Hai-Su Dai, Zhi-Peng Liu, Hua-Qiang Bi, De-Hong Tan, Yu-Le Luo

Int J Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long noncoding RNA HAND2-AS1 reduced the viability of hepatocellular carcinoma via targeting microRNA-300/SOCS5 axis.
Hua-Qiang Bi, Zhong-Hui Li, Hui Zhang

Hepatobiliary Pancreat Dis Int· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Spontaneous regression of recurrent hepatocellular carcinoma after liver resection: a case report].
Heng Huang, Wei Liu, Zhi-qing Yang, Hua-qiang Bi, Xiao-wu Li, Ping Bie

Zhonghua Gan Zang Bing Za Zhi· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis